Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0054 | 0.2299 | 0.2871 |
Plasmodium falciparum | thioredoxin reductase | 0.0054 | 0.2299 | 1 |
Brugia malayi | RNA binding protein | 0.0142 | 0.8006 | 1 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0137 | 0.7701 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0052 | 0.2184 | 0.2728 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0021 | 0.0121 | 0.0157 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0021 | 0.0121 | 1 |
Brugia malayi | glutathione reductase | 0.0054 | 0.2299 | 0.2871 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0052 | 0.2184 | 0.2184 |
Schistosoma mansoni | tar DNA-binding protein | 0.0142 | 0.8006 | 0.8006 |
Loa Loa (eye worm) | RNA binding protein | 0.0142 | 0.8006 | 1 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0054 | 0.2299 | 0.2762 |
Trypanosoma brucei | trypanothione reductase | 0.0054 | 0.2299 | 1 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0021 | 0.0121 | 0.0151 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0052 | 0.2184 | 0.2728 |
Echinococcus multilocularis | tar DNA binding protein | 0.0142 | 0.8006 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0021 | 0.0121 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0.0121 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0021 | 0.0121 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0052 | 0.2184 | 0.2728 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0142 | 0.8006 | 1 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0054 | 0.2299 | 0.2871 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0123 | 0.6806 | 0.8837 |
Brugia malayi | TAR-binding protein | 0.0142 | 0.8006 | 1 |
Leishmania major | trypanothione reductase | 0.0054 | 0.2299 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0021 | 0.0121 | 0.0524 |
Plasmodium vivax | glutathione reductase, putative | 0.0054 | 0.2299 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0019 | 0 | 0.5 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0052 | 0.2184 | 0.2617 |
Schistosoma mansoni | tar DNA-binding protein | 0.0142 | 0.8006 | 0.8006 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0021 | 0.0121 | 0.0151 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0137 | 0.7701 | 1 |
Mycobacterium tuberculosis | Probable reductase | 0.0123 | 0.6806 | 0.8837 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.0121 | 0.0121 |
Toxoplasma gondii | thioredoxin reductase | 0.0054 | 0.2299 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0054 | 0.2299 | 1 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0123 | 0.6806 | 0.8837 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0052 | 0.2184 | 0.2728 |
Schistosoma mansoni | tar DNA-binding protein | 0.0142 | 0.8006 | 0.8006 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.0121 | 0.0524 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0137 | 0.7701 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0052 | 0.2184 | 0.2184 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0052 | 0.2184 | 0.2184 |
Schistosoma mansoni | tar DNA-binding protein | 0.0142 | 0.8006 | 0.8006 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0123 | 0.6806 | 0.8837 |
Loa Loa (eye worm) | glutathione reductase | 0.0054 | 0.2299 | 0.2762 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0123 | 0.6806 | 0.8837 |
Echinococcus granulosus | tar DNA binding protein | 0.0142 | 0.8006 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0021 | 0.0121 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0021 | 0.0121 | 0.0151 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0021 | 0.0121 | 0.0524 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0021 | 0.0121 | 0.5 |
Brugia malayi | Thioredoxin reductase | 0.0054 | 0.2299 | 0.2871 |
Plasmodium falciparum | glutathione reductase | 0.0054 | 0.2299 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0142 | 0.8006 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0054 | 0.2299 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0052 | 0.2184 | 0.2728 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0137 | 0.7701 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.0121 | 0.0524 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.0121 | 0.0121 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0.0121 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0142 | 0.8006 | 0.8006 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.0121 | 0.0524 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0021 | 0.0121 | 0.0524 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0142 | 0.8006 | 1 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0123 | 0.6806 | 0.8837 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0054 | 0.2299 | 0.2985 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.0121 | 0.0524 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI (functional) | = 6 % | Cytotoxicity against human KB cells assessed as growth inhibition at 1 ug/ml after 24 hrs by MTT assay | ChEMBL. | 20403695 |
GI (functional) | = 7.27 % | Cytotoxicity against human KB cells assessed as growth inhibition at 0.1 ug/ml after 24 hrs by MTT assay | ChEMBL. | 20403695 |
GI (functional) | = 7.32 % | Cytotoxicity against human Bel7402 cells assessed as growth inhibition at 1 ug/ml after 24 hrs by MTT assay | ChEMBL. | 20403695 |
GI (functional) | = 12.58 % | Cytotoxicity against human PC3 cells assessed as growth inhibition at 1 ug/ml after 24 hrs by MTT assay | ChEMBL. | 20403695 |
GI (functional) | = 14.16 % | Cytotoxicity against human Bel7402 cells assessed as growth inhibition at 10 ug/ml after 24 hrs by MTT assay | ChEMBL. | 20403695 |
GI (functional) | = 14.94 % | Cytotoxicity against human PC3 cells assessed as growth inhibition at 0.1 ug/ml after 24 hrs by MTT assay | ChEMBL. | 20403695 |
GI (functional) | = 14.99 % | Cytotoxicity against human KB cells assessed as growth inhibition at 10 ug/ml after 24 hrs by MTT assay | ChEMBL. | 20403695 |
GI (functional) | = 17.25 % | Cytotoxicity against human NCI-H460 cells assessed as growth inhibition at 0.1 ug/ml after 24 hrs by MTT assay | ChEMBL. | 20403695 |
GI (functional) | = 19.12 % | Cytotoxicity against human NCI-H460 cells assessed as growth inhibition at 1 ug/ml after 24 hrs by MTT assay | ChEMBL. | 20403695 |
GI (functional) | = 29.23 % | Cytotoxicity against human NCI-H460 cells assessed as growth inhibition at 10 ug/ml after 24 hrs by MTT assay | ChEMBL. | 20403695 |
GI (functional) | = 42.46 % | Cytotoxicity against human PC3 cells assessed as growth inhibition at 10 ug/ml after 24 hrs by MTT assay | ChEMBL. | 20403695 |
GI (functional) | = 49.69 % | Cytotoxicity against human Bel7402 cells assessed as growth inhibition at 100 ug/ml after 24 hrs by MTT assay | ChEMBL. | 20403695 |
GI (functional) | = 65.14 % | Cytotoxicity against human NCI-H460 cells assessed as growth inhibition at 100 ug/ml after 24 hrs by MTT assay | ChEMBL. | 20403695 |
GI (functional) | = 73.33 % | Cytotoxicity against human KB cells assessed as growth inhibition at 100 ug/ml after 24 hrs by MTT assay | ChEMBL. | 20403695 |
GI (functional) | = 75.45 % | Cytotoxicity against human PC3 cells assessed as growth inhibition at 100 ug/ml after 24 hrs by MTT assay | ChEMBL. | 20403695 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.